Related Experiment Videos
[Adjuvant therapy for colon cancer].
1Institut für medizinische Onkologie Universität Bern und Inselspital CH-3010 Bern. martin.fey@insel.ch
Schweizerische Medizinische Wochenschrift
|December 29, 2000
Summary
Adjuvant chemotherapy offers modest benefits for node-positive colon cancer patients. Routine use in node-negative cases is not yet supported, pending further research and molecular marker development for personalized treatment.
Area of Science:
- Oncology
- Molecular Biology
- Surgical Oncology
Context:
- Locally advanced colon cancer often requires more than surgical resection.
- Adjuvant chemotherapy shows a modest benefit in node-positive patients.
- Evidence for routine adjuvant treatment in node-negative colon cancer is limited.
Purpose:
- To review the current role and future directions of adjuvant therapy in colon cancer.
- To highlight the evolving understanding of colon cancer biology and treatment strategies.
Summary:
- Surgery alone is insufficient for many advanced colon cancers.
- 5-fluorouracil combinations are standard, with new drugs under investigation.
- Molecular markers are anticipated to refine patient selection for adjuvant therapy.
Impact:
- Colon cancer management is shifting towards a multimodal approach.
- Personalized treatment selection using molecular markers is expected.
- Improved outcomes are anticipated with integrated therapeutic strategies.